Flen Health

Foundation date

17/11/2000

Sector

#Biotechnology - Therapeutics

Subsector

Therapeutic areas

Flen Health develops innovative topical products for improving the quality of life of patients that suffer from infections or inflammations. Flen Health started its activities in wound care - including burns, venous and diabetic ulcers, bedsores, grazes and post-operative wounds - and wound-bed preparation.

Upcoming events

Latest news

  • Mayne Pharma and Mithra announce FDA approval of HALOETTE®, a generic version of NUVARING®

    Monday August 8th 2022

  • S-Biomedic welcomes Pascal Yvon to lead its B2B commercial activities

    Tuesday August 2nd 2022

  • Celyad Oncology announces FDA lifts clinical hold of CYAD-101-002 Phase 1b trial

    Monday August 1st 2022

Jobs by Flen Health